Emmanuel De Billy

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy.

Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: May 04, 2026

FECH, a novel metabolic target influencing CAR T-cell phenotype and function.

FECH, a novel metabolic target influencing CAR T-cell phenotype and function.

Journal: Biomarker research

Published: February 18, 2026

GIT1 loss of function causes a recognizable syndromic neurodevelopmental disorder.

GIT1 loss of function causes a recognizable syndromic neurodevelopmental disorder.

Journal: Brain : a journal of neurology

Published: November 26, 2025

Human DEAH-box helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing in tumour cells.

Human DEAH-box helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing in tumour cells.

Journal: NAR cancer

Published: September 25, 2025

Proteasome inhibition promotes Foxn1 expression in thymic epithelial cells and induces thymic regeneration in mice.

Proteasome inhibition promotes Foxn1 expression in thymic epithelial cells and induces thymic regeneration in mice.

Journal: Cell death and differentiation

Published: June 06, 2025

GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system.

GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous system.

Journal: NPJ precision oncology

Published: January 20, 2025

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target.

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target.

Journal: Frontiers in immunology

Published: December 15, 2023

Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas.

Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas.

Journal: Cell & bioscience

Published: May 11, 2023

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies.

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies.

Journal: Journal of medicinal chemistry

Published: April 05, 2023

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle.

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle.

Journal: Diagnostics (Basel, Switzerland)

Published: August 04, 2022

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 28, 2022

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

Journal: Neuro-oncology

Published: December 29, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026